The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
IgA Nephropathy
Abstract
IgA nephropathy is the most common form of primary glomerulonephritis in the world and is also the most common cause of end-stage renal disease in patients with primary glomerulopathy. This article discusses current views on the pathogenesis, pathophysiology, clinical course, and treatment of this important glomerular disease. Although clinical trials have suggested that therapies such as glucocorticoids, n–3 fatty acids, and angiotensin-converting–enzyme inhibitors are efficacious, more definitive treatment is being sought.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corticosteroids in IgA nephropathy: a randomised controlled trial
Pozzi, C., Bolasco, P., Fogazzi, G., Andrulli, S., Altieri, P., Ponticelli, C., & Locatelli, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03563-6 · Cited by 532
Predicting renal outcome in IgA nephropathy.
Radford, M. G., Donadio, J. V., Bergstralh, E. J., & Grande, J. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v82199 · Cited by 440
Self-citationA Controlled Trial of Fish Oil in IgA Nephropathy
Donadio, J. V., Bergstralh, E. J., Offord, K. P., Spencer, D. C., & Holley, K. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311804 · Cited by 408
Self-citationProteinuria as a modifiable risk factor for the progression of non-diabetic renal disease
Jafar, T. H., Stark, P. C., Schmid, C. H., Landa, M., Maschio, G., Marcantoni, C., De Jong, P. E., De Zeeuw, D., Shahinfar, S., Ruggenenti, P., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031131.x · Cited by 377
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
Tomana, M., Matoušovic, K., Julian, B. A., Radl, J., Konecný, K., & Mestecky, J. (1997) · Kidney International · doi:10.1038/ki.1997.361 · Cited by 341
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23
Gharavi, A. G., Yan, Y., Scolari, F., Schena, F. P., Frasca, G. M., Ghiggeri, G. M., Cooper, K., Amoroso, A., Viola, B. F., Battini, G. G., et al. (2000) · Nature Genetics · doi:10.1038/81677 · Cited by 332
Controlled Prospective Trial of Prednisolone and Cytotoxics in Progressive IgA Nephropathy
Ballardie, F. W., & Roberts, I. S. D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131142 · Cited by 317
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients
Allen, A. C., Bailey, E. M., Brenchley, P. E., Buck, K., Barratt, J., & Feehally, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060003969.x · Cited by 311
Galla, J. H. (1995) · Kidney International · doi:10.1038/ki.1995.50 · Cited by 301
Maisonneuve, P., Agodoa, L., Gellert, R., Stewart, J. H., Buccianti, G., Lowenfels, A. B., Wolfe, R. A., Jones, E., Disney, A. P. S., Briggs, D., et al. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70316-7 · Cited by 294
Alamartine, E., Sabatier, J.-C., Guerin, C., Berliet, J.-M., & Berthoux, F. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80284-8 · Cited by 283
The human IgA system: A reassessment
Mestecky, J., Russell, M. W., Jackson, S., & Brown, T. A. (1986) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(86)90073-5 · Cited by 259
Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy
Russo, D., Minutolo, R., Pisani, A., Esposito, R., Signoriello, G., Andreucci, M., & Balletta, M. M. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.25176 · Cited by 247
Ibels, L. S., & Györy, A. Z. (1994) · Medicine · doi:10.1097/00005792-199403000-00002 · Cited by 244
Russo, D., Pisani, A., Balletta, M. M., De Nicola, L., Savino, F. A., Andreucci, M., & Minutolo, R. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70416-6 · Cited by 243
IgA nephropathy, the most common glomerulonephritis worldwide
Julian, B. A., Waldo, F. B., Rifai, A., & Mestecky, J. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90019-8 · Cited by 242
Role of Transforming Growth Factor- in Tissue Injury and Repair
Grande, J. P. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-214-44066 · Cited by 241
Self-citationThe incidence of biopsy‐proven glomerulonephritis in Australia
Briganti, E. M., Dowling, J., Finlay, M., Hill, P. A., Jones, C. L., Kincaid‐Smith, P. S., Sinclair, R., McNeil, J. J., & Atkins, R. C. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.7.1364 · Cited by 232
The Long-Term Outcome of Patients with IgA Nephropathy Treated with Fish Oil in a Controlled Trial
DONADIO, J. V., GRANDE, J. P., BERGSTRALH, E. J., DART, R. A., LARSON, T. S., & SPENCER, D. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1081772 · Cited by 209
Self-citationInterleukin 6 is an autocrine growth factor for mesangial cells
Ruef, C., Budde, K., Lacy, J., Northemann, W., Baumann, M., Sterzel, R. B., & Coleman, D. L. (1990) · Kidney International · doi:10.1038/ki.1990.193 · Cited by 194
Ponticelli, C., Traversi, L., Feliciani, A., Cesana, B. M., Banfi, G., & Tarantino, A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00006.x · Cited by 190
Cattran, D. C., Greenwood, C., & Ritchie, S. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80980-2 · Cited by 172
Evidence for genetic factors in the development and progression of IgA nephropathy
Hsu, S. I.-H., Ramirez, S. B., Winn, M. P., Bonventre, J. V., & Owen, W. F. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00032.x · Cited by 171
A Randomized Trial of High-Dose Compared with Low-Dose Omega-3 Fatty Acids in Severe IgA Nephropathy
DONADIO, J. V., LARSON, T. S., BERGSTRALH, E. J., & GRANDE, J. P. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v124791 · Cited by 160
Self-citationReceptor-mediated binding and uptake of immunoglobulin a by human liver
Tomana, M., Kulhavy, R., & Mestecky, J. F. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90252-1 · Cited by 155
ACE Inhibitors versus AT1 Receptor Antagonists in Patients with Chronic Renal Disease
Hilgers, K. F., & Mann, J. F. E. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341100 · Cited by 126
Management of IgA nephropathy: Evidence-based recommendations
Nolin, L., & Courteau, M. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07008.x · Cited by 124
PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis
Niemir, Z. I., Stein, H., Noronha, I. L., Krüger, C., Andrássy, K., Ritz, E., & Waldherr, R. (1995) · Kidney International · doi:10.1038/ki.1995.443 · Cited by 121
Hogg, R. J., Silva, F. G., Wyatt, R. J., Reisch, J., Argyle, J. C., & Savino, D. A. (1994) · Pediatric Nephrology · doi:10.1007/bf00868251 · Cited by 121
Epidemiology of idiopathic glomerular disease: A prospective study
Tiebosch, A. T. M. G., Wolters, J., Frederik, P. M., van der Wiel, T. W. M., Zeppenfeldt, E., Vriesman, P. J. C. V. B., & van Rie, H. (1987) · Kidney International · doi:10.1038/ki.1987.179 · Cited by 112
Shoji, T., Nakanishi, I., Suzuki, A., Hayashi, T., Togawa, M., Okada, N., Imai, E., Hori, M., & Tsubakihara, Y. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70326-x · Cited by 107
EICOSAPENTAENOIC ACID AND IgA NEPHROPATHY
Hamazaki, T., Tateno, S., & Shishido, H. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92355-9 · Cited by 105
Wyatt, R. J., Julian, B. A., Baehler, R. W., Stafford, C. C., McMorrow, R. G., Ferguson, T., Jackson, E., Woodford, S. Y., Miller, P. M., & Kritchevsky, S. B. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v95853 · Cited by 105
Low incidence of IgA nephropathy in Blacks
Jennette, J. C., Wall, S. D., & Wilkman, A. S. (1985) · Kidney International · doi:10.1038/ki.1985.222 · Cited by 102
Donadío, J. V., & Grande, J. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v881324 · Cited by 92
Self-citationIgA Nephropathy: Morphologic Expression and Pathogenesis
Emancipator, S. N. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)81011-0 · Cited by 86
Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy
Harper, S. J., Pringle, J. H., Wicks, A. C. B., Hattersley, J., Layward, L., Allen, A., Gillies, A., Lauder, I. J., & Feehally, J. (1994) · Kidney International · doi:10.1038/ki.1994.110 · Cited by 85
Varis, J., Rantala, I. S., Pasternack, A. I., et al. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.7.607 · Cited by 82
ACE gene polymorphism and IgA nephropathy: An ethnically homogeneous study and a meta-analysis
Schena, F. P., D’Altri, C., Cerullo, G., Manno, C., & Gesualdo, L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060002732.x · Cited by 74
Schmidt, S., Stier, E., Hartung, R., Stein, G., Bahnisch, J., Woodroffe, A. J., Clarkson, A. R., Ponticelli, C. E., Campise, M., Mayer, G. J., et al. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90435-2 · Cited by 73
Rena, G., Begg, F., Ross, A. H., MacKenzie, C., McPhee, I., Campbell, L., Huston, E., Sullivan, M., & Houslay, M. D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12557-6 · Cited by 73
Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo
Grande, J. P., Walker, H. J., Holub, B. J., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00930.x · Cited by 66
Self-citationThe Effect of Fish-Oil Dietary Supplement on the Progression of Mesangial IgA Glomerulonephritis
Cheng, I. K. P., Chan, P. C. K., & Chan, M. K. (1990) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/5.4.241 · Cited by 66
Bannister, K. M., Weaver, A., Clarkson, A. R., & Woodroffe, A. J. (2015) · Contributions to nephrology · doi:10.1159/000423895 · Cited by 59
B�n�, M. C., de Ligny, B. H., Kessler, M., Foliguet, B., & Faure, G. C. (2015) · Contributions to nephrology · doi:10.1159/000422408 · Cited by 59
Hogg, R. J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90445-x · Cited by 42
Molecular Genetics in IgA Nephropathy
Galla, J. H. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000045969 · Cited by 32
Cheng, I. K. P., FANG, G., WONG, M., JI, Y., Chan, K., & YEUNG, H. W. D. (1998) · Nephrology · doi:10.1046/j.1440-1797.1998.d01-12.x · Cited by 23
Cited by
Wyatt, R. J., & Julian, B. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1206793 · Cited by 1,222
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Barbour, S. J., Coppo, R., Zhang, H., Liu, Z.-H., Suzuki, Y., Matsuzaki, K., Katafuchi, R., Er, L., Espino-Hernandez, G., Kim, S. J., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0600 · Cited by 478
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Berthoux, F., Mohey, H., Laurent, B., Mariat, C., Afiani, A., & Thibaudin, L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040355 · Cited by 361
Yu, X.-Q., Li, M., Zhang, H., Low, H.-Q., Wei, X., Wang, J.-Q., Sun, L.-D., Sim, K.-S., Li, Y., Foo, J.-N., et al. (2012) · Nature Genetics · doi:10.1038/ng.1047 · Cited by 312
Metadata
- Authors
- Donadio, J. V., & Grande, J. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-09-05
- Volume
- 347
- Issue
- 10
- Pages
- 738-748
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4241655994
- Cited by
- 661
- References
- 48
- FWCI
- 13.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.